The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms

Frontiers in Endocrinology
Chenhe ZhaoXinhua Qu

Abstract

The impact of antidiabetic drugs on bone metabolism is drawing increasing attention due to the discovery of a correlation between type 2 diabetes mellitus (T2DM) and osteoporosis. Glucagon-like peptide-1 (GLP-1) receptor agonists are a novel and promising class of drugs for T2DM, which may also have clinical applications in bone tissue disorders. This review examines the impact of GLP-1 on bone metabolism, including enhancement of bone mineral density and improvement of bone quality. However, the precise effect of GLP-1 on fracture risk has not been unambiguously defined. This review also summarizes our current understanding of the mechanisms by which GLP-1 affects bone metabolism. GLP-1 may act on bone by promoting bone formation, inhibiting bone resorption, and affecting the coordination of the two processes. We describe molecular pathways and proteins, such as Wnt and calcitonin, that are associated with GLP-1 and bone tissue. The specific processes and related molecular mechanisms of the effects of GLP-1 on bone metabolism need to be further explored and clarified.

References

Jul 1, 1995·The Journal of Endocrinology·M L Villanueva-PeñacarrilloI Valverde
Jan 10, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L B JensenO H Sørensen
Sep 8, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·E M HaugeF Melsen
Jan 17, 2002·Bone·N H BjarnasonC Christiansen
Jun 22, 2002·Nature·Yuehua JiangCatherine M Verfaillie
Nov 25, 2003·The EMBO Journal·David G WinklerJohn A Latham
Oct 28, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P Vestergaard
Jan 25, 2008·The Journal of Biological Chemistry·Zhengyu Liu, Joel F Habener
Feb 17, 2009·Calcified Tissue International·Bernardo Nuche-BerenguerMaría L Villanueva-Peñacarrillo
Jul 10, 2009·Regulatory Peptides·Bernardo Nuche-BerenguerMaría L Villanueva-Peñacarrillo
Oct 20, 2009·The Journal of Clinical Endocrinology and Metabolism·Kristine J HareTina Vilsbøll
Dec 31, 2009·American Journal of Physiology. Endocrinology and Metabolism·C SanzE Blázquez
May 28, 2010·Journal of Cellular Physiology·Bernardo Nuche-BerenguerMaría L Villanueva-Peñacarrillo
Mar 5, 2011·The Journal of Endocrinology·Bernardo Nuche-BerenguerMaría L Villanueva-Peñacarrillo
Aug 2, 2011·BMC Physiology·Elda L Pacheco-PantojaWilliam D Fraser
Dec 21, 2011·The Journal of Clinical Investigation·Benjamin J LamontDaniel J Drucker
Feb 22, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Xue MaXiaoxing Luo
Aug 6, 2013·The Journal of Endocrinology·Guillaume MabilleauDaniel Chappard
Aug 17, 2014·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A MieczkowskaG Mabilleau
Dec 4, 2014·Metabolic Syndrome and Related Disorders·Rabia TerziÖmer Demirtaş
May 29, 2015·Journal of Cellular Physiology·Sity Aishah MansurGuillaume Mabilleau
Jun 5, 2015·The Journal of Clinical Endocrinology and Metabolism·Eva W IepsenSigne S Torekov
Jun 26, 2015·Endocrine·Han-Xiao SunBei Tao
Nov 18, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Matthew P GilbertRichard E Pratley

❮ Previous
Next ❯

Citations

Aug 29, 2017·International Journal of Molecular Sciences·Jenq-Lin YangShang-Der Chen
Nov 24, 2018·Diabetes/metabolism Research and Reviews·Evangelia KalaitzoglouKathryn M Thrailkill
Nov 4, 2017·The Journal of Clinical Endocrinology and Metabolism·Mikkel B ChristensenFilip K Knop
Sep 22, 2019·Scientific Reports·María Cristina Montes CastilloMiguel Delgado Rodríguez
Nov 16, 2018·Molecular Medicine Reports·Martha Cristina Diaz-FrancoJose Rafael Villafan-Bernal
Jun 3, 2018·Hormones : International Journal of Endocrinology and Metabolism·Charikleia StefanakiGeorge P Chrousos
Mar 9, 2019·The Journal of Clinical Endocrinology and Metabolism·Natasha Chidekel BergmannFilip Krag Knop
Nov 28, 2020·Life Sciences·Hao ChenJing Xie
Jan 13, 2021·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A KreitmanS A Shapses
Feb 2, 2021·Current Osteoporosis Reports·Julie Kristine KnudsenSuzette Sørensen
Jan 26, 2021·International Journal of Endocrinology·Yue SunNing Xia
Jul 3, 2020·Molecular and Cellular Endocrinology·Yun LiHongyun Lu
Jul 3, 2021·International Journal of Molecular Sciences·Hideki KitauraItaru Mizoguchi
Jul 27, 2021·Experimental Biology and Medicine·Ying ZhouYang Wang
Jul 27, 2021·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·N PanahiB Larijani
Nov 2, 2021·Frontiers in Endocrinology·Yu-Sheng ZhangBao-Cheng Xie
Jul 17, 2019·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Özhan PazarciYalkin Çamurcu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Related Papers

The Annals of Pharmacotherapy
Sarah L Anderson, Jennifer M Trujillo
Expert Opinion on Investigational Drugs
Mikkel ChristensenJens J Holst
© 2022 Meta ULC. All rights reserved